Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1

Conditions

Skin Carcinoma 1Carcinoma, Renal Cell 1

Interventions

Specimen Handling 642pembrolizumab 565Magnetic Resonance Spectroscopy 548Carboplatin 426Cisplatin 377Cyclophosphamide 374Biopsy 365Paclitaxel 306Nivolumab 303Gemcitabine 303Radiotherapy 274Bevacizumab 240Dexamethasone 209fludarabine 207Docetaxel 191durvalumab 183atezolizumab 177Oxaliplatin 174venetoclax 168Fluorouracil 167Rituximab 166Pemetrexed 164Capecitabine 161Radiation 159Doxorubicin 159Radiosurgery 150Etoposide 137Ipilimumab 135Leucovorin 133Lenalidomide 132

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Aftercare × 90 days × Clear all
NCT00918775 2026-04-15

Follow-up After Metastasectomy in Patients With Kidney Cancer

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
86 enrolled
Genitourinary

Carcinoma, Renal Cell

NCT07032701 2026-04-02

A Disposable Negative Pressure Wound Therapy Device (SNaP) to Promote Wound Healing in the Lower Limbs Following Mohs Micrographic Surgery for Non-melanoma Skin Cancer

Jonsson Comprehensive Cancer Center

Phase NA Not yet recruiting
60 enrolled

Skin Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡